Páez, David
Tobeña, María
Fernández-Plana, Julen
Sebio, Ana
Virgili, Anna C.
Cirera, Lluís
Barnadas, Agustí
Riera, Pau
Sullivan, Ivana
Salazar, Juliana
Article History
Received: 27 March 2018
Revised: 1 November 2018
Accepted: 6 November 2018
First Online: 26 December 2018
<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate
: All subjects gave written consent. The study protocol was approved by the hospital’s ethics committee. The study was performed according to the guidelines of the Declaration of Helsinki.
: All subjects gave written consent for publication:
: D.P. has declared scientific advisory role for Amgen, Sanofi, Merck Serono, and Servier. M.T. has declared scientific advisory role for Amgen, Sanofi, and F. Hoffmann-La Roche Ltd. A.B. has declared scientific advisory role and has participated on the speaker’s bureau for Novartis, Pfizer, F. Hoffmann-La Roche Ltd, MSD, Pierre Fabre, Lilly. and Pallex. A.B. has received institutional grant support from F. Hoffmann-La Roche Ltd, Pfizer, Lilly. and Bristol Myers Squibb. The other authors declare no competing interests.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).